Aggregated News
It was January when headlines nationwide trumpeted Illumina’s introduction of the $1,000 genome. The story in Forbes Magazine, “The $1,000 Genome Arrives—For Real, This Time,” was typical of much of the press coverage.
Because pathology groups and clinical laboratories have much at stake in the race to the $1,000 whole-human genome sequence, it is important to know the real facts about the cost and performance of Illumina’s latest generation of genome sequencing technology. After all, corporate press releases are intentionally designed to present a company’s product in the best possible light.
Illumina’s Biggest Gene Sequencers Each Cost $10 Million
In its story, Forbes Magazine reported that Illumina had already sold three of its HiSeqX Ten machines at a cost of $10 million each and expected to sell at least five such systems during 2014.
One expert who says there is more to this story than what appeared in most media coverage is Katherine Tynan, Ph.D., of Tynan Consulting, LLC, in San Francisco, California. Tynan is a strategic consultant for diagnostics companies.
She said that...